BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GE Healthcare Redefines Comfort, Confidence and Connectivity in Radiology at Radiological Society of North America (RSNA) Conference


11/26/2012 11:09:13 AM

CHICAGO--(BUSINESS WIRE)--Today at RSNA 2012, GE Healthcare (NYSE: GE) unveiled four medical technologies that will change the way radiology works today and evolves in the future. First, taking an industry-leading step toward more comfortable Magnetic Resonance (MR) patient exams, GE Healthcare’s 510(k) pending Silent Scan* technology reduces the typical noise made during MR exams from a cymbal to a thimble, cutting overall system noise to near ambient levels. Second, GE Healthcare’s Universal Viewer solution improves radiologists’ connectivity and workflow like never before – integrating more types of imaging systems into an intuitive, robust platform that can have a significant impact on productivity. Third, GE Healthcare’s acquisition of a unique breast ultrasound technology positions the company with the widest portfolio of breast cancer imaging solutions in the world, and as the only company offering breast cancer diagnosis and screening capabilities via ultrasound in the United States. . Finally, InSightec Ltd. is proud to announce US Food and Drug Administration (FDA) approval for the ExAblate MRI guided focused ultrasound treatment of painful bone metastases in patients who are not candidates for or refuse to undergo radiation treatment.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->